Condition
Traveler's Diarrhea
Traveler's diarrhea is a gut illness, usually caused by bacteria such as E. coli from contaminated food or water, that irritates the intestine and brings loose, frequent stools. The evidence is strongest for Saccharomyces boulardii, a probiotic yeast, and for oral rehydration salts, which replace lost fluids. Evidence for the rest is thinner: a small study of 90 people found colostrum eased abdominal pain, while berberine and charcoal remain limited.
- Supplements studied
- 1
- Graded outcomes
- 1
- Trials
- 2
- People studied
- 110
Evidence by supplement
- Strong
- Moderate
- Limited
- Very limited
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Abdominal Pain Small Improvement | Improves (the measure goes down) | Small effect | 90 people | |||
| Diarrhea Symptoms | Improves (the measure goes down) | 3 studies | 130 people | |||
Studies that measured diarrhea symptoms
| ||||||
| Intestinal Parasites | Improves (the measure goes up) | 2 studies | 110 people | |||
Studies that measured intestinal parasites | ||||||
Key findings
- Abdominal PainImproves (the measure goes down)
The Traveler's Diarrhea Prevention and Treatment protocol
2 primary supplements · 6 supporting supplements
- Saccharomyces boulardii250–500 mg (5–10 billion CFU) daily, starting before travel and continuing during trip
- Lactobacillus GG10–20 billion CFU daily during travel
Shop the evidence-backed picks
The collection holds the supplements we grade A or B for its theme, in products from the Fullscript catalog. It opens in our Fullscript store. You can look through it without signing in; Fullscript asks for a free account to order.
We earn from purchases made in our Fullscript store, and links to Fullscript, iHerb or Thorne carry our referral, so we may earn a commission at no extra cost to you. Grades come from the research and never change based on what we earn. Full disclosure
Studies cited
5 studies from PubMed
- Treatment of diarrhoea in human immunodeficiency virus-infected patients with immunoglobulins from bovine colostrum
- Treatment of severe diarrhea caused by Cryptosporidium parvum with oral bovine immunoglobulin concentrate in patients with AIDS
- Lack of prophylactic efficacy of an enteric-coated bovine hyperimmune milk product against enterotoxigenic Escherichia coli challenge administered during a standard meal
- Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Escherichia coli
- Randomized control trials using a tablet formulation of hyperimmune bovine colostrum to prevent diarrhea caused by enterotoxigenic Escherichia coli in volunteers